Cambridge scientists are among the new Fellows announced today by the Academy of Medical Sciences.
The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration. Professor Dame Anne Johnson, President of the Academy of Medical Sciences
The Academy of Medical Sciences has elected 50 prominent biomedical and health scientists to its respected and influential Fellowship. The new Fellows have been selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.
Professor Dame Anne Johnson, President of the Academy of Medical Sciences, said: “I am truly delighted to welcome these 50 new Fellows to the Academy’s Fellowship, and I offer my congratulations to each of them on their exceptional contribution to biomedical and hea
The Academy of Medical Sciences has elected 50 prominent biomedical and health scientists to its respected and influential Fellowship. The new Fellows have
Study discovers harmful inflammatory protein in patients with symptomatic tuberculosis
A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB).
Researchers say, by targeting the IL-17 cytokine, a component produced naturally by the immune system in response to infection, excessive and damaging lung inflammation caused by TB may be significantly reduced to help speed up patient recovery.
TB is an infection caused by the bacterium Mycobacterium tuberculosis and is the leading cause of death from infections worldwide. The World Health Organisation estimates that 1.4 million people died of TB disease worldwide in 2019.
Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19 thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
E-Mail
A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB).
Researchers say, by targeting the IL-17 cytokine, a component produced naturally by the immune system in response to infection, excessive and damaging lung inflammation caused by TB may be significantly reduced to help speed up patient recovery.
TB is an infection caused by the bacterium Mycobacterium tuberculosis and is the leading cause of death from infections worldwide. The World Health Organisation estimates that 1.4 million people died of TB disease worldwide in 2019.
Explaining the experimental study, lead author Dr Gabriele Pollara (UCL Division of Infection & Immunity), said: For most people the body s immune response to TB is a vital defence strategy to contain the infection, but when disease develops it can worsen symptoms, cause lung damage, and promote transmission of the infection to others.